April 2008
You are currently browsing the articles from acne control for skin written in the month of April 2008.
Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, announced today the publication of a study of CLENZIderm M.D.(TM) Acne Therapeutic System in the April 2008 issue of Cosmetic Dermatology. The study included three clinical trials of patients with mild-to-moderate acne. According to the publication, the 3-step CLENZIderm M.D.(TM) Acne …
Written by admin on April 30th, 2008 with no comments.
Read more articles on acne control for skin.
LONG BEACH, Calif.—-Obagi Medical Products, Inc. , a leader in topical aesthetic and therapeutic skin health systems, announced today the publication of a study of CLENZIderm M.D.™ Acne Therapeutic System in the April 2008 issue of Cosmetic Dermatology.
Written by admin on April 30th, 2008 with no comments.
Read more articles on acne control for skin.
A jury has awarded a Layton woman $10 million because it says the manufacturer of the acne medication Accutane downplays the drug’s risks.
Written by admin on April 30th, 2008 with no comments.
Read more articles on acne control for skin.
Kochi, Apr 29: The Rs 112 crore turnover Ozone Group is targeting an additional Rs 100 crore turnover this year, driven by the sales of its newly launched no marks anti-acne cream ‘Zap n Clear,’ Company CMD S C Sehgal said today.
Written by admin on April 30th, 2008 with no comments.
Read more articles on acne control for skin.
La Jolla, CA and Hong Kong, China (PRWEB) April 28, 2008 — Skin care development company, Cosmederm Technologies (www.cosmederm.com) announced today a joint venture agreement with Health Sciences Limited, a diversified group of companies based in Hong Kong, focused on promoting quality health care products and services.
Written by admin on April 30th, 2008 with no comments.
Read more articles on acne control for skin.
« Older articles
No newer articles
